[{"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1048-2023", "product_description": "vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6012-1.", "product_quantity": "2,640 Syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-273867, Exp.9/10/2023; 17-272606, Exp.8/20/2023; 17-272225, 8/13/2023; 17-272036, Exp. 8/9/2023; 17-271503, Exp. 7/31/2023; 17-271427, Exp. 7/30/2023; 17-271264, Exp. 7/26/2023; 17-270970, Exp.7/23/2023; 17-270784, Exp. 7/19/2023; 17-270674, Exp. 7/18/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1011-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10% with CALCIUM and HEPARIN, IV Bags, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0422-1", "product_quantity": "420 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251208, Exp. 7/10/2023; 36-252137, Exp. 7/16/2023; 36-254920, 36-254926, Exp. 7/22/2023; 36-256529, Exp. 7/29/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1015-2023", "product_description": "CARDIOPLEGIA SOLUTION, IV Bag, Total Volume = 1818 mL, CRYSTALLOID INDUCTION, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0216-1", "product_quantity": "48 bags.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-257024, Exp. 8/14/2023."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92494", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1149", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "USA Nationwide", "recall_number": "D-0879-2023", "product_description": "Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ  NDC# 55566-6500-03", "product_quantity": "N/A", "reason_for_recall": "cGMP deviations: potential for Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20230612", "center_classification_date": "20230626", "termination_date": "20240805", "report_date": "20230705", "code_info": "AA200A, AA201A, Exp. 12/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["STELLALIFE VEGA ORAL CARE COCONUT"], "generic_name": ["RISNE"], "manufacturer_name": ["StellaLife, Inc."], "product_ndc": ["69685-113"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["APIS MELLIFERA", "AZADIRACHTA INDICA BARK", "CALENDULA OFFICINALIS FLOWER", "ECHINACEA PURPUREA", "OKOUBAKA AUBREVILLEI BARK", "PHOSPHORUS", "PLANTAGO MAJOR", "STRONTIUM", "THUJA OCCIDENTALIS LEAFY TWIG"], "spl_id": ["ca787fd0-fddb-8961-e053-2a95a90a9d88"], "spl_set_id": ["b8694e38-dc05-77c9-e053-2995a90a36e4"], "package_ndc": ["69685-113-16"], "is_original_packager": [true], "upc": ["0850019861020"], "nui": ["N0000185021", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0002274"], "pharm_class_epc": ["Standardized Insect Venom Allergenic Extract [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Bee Venoms [CS]"], "unii": ["7S82P3R43Z", "G580B439YI", "P0M7O4Y7YD", "QI7G114Y98", "MK2074187Z", "27YLU75U4W", "W2469WNO6U", "YZS2RPE8LE", "1NT28V9397"]}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0887-2023", "product_description": "StellaLife VEGA Oral Care Rinse, 16 fl oz (473 ml) bottles, Coconut, Distributed by: StellaLife, Aventura, FL NDC 69685-113-16", "product_quantity": "16,587 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2396, exp. date Apr-24", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0948-2023", "product_description": "vancomycin 1 g/250 mL added to 0.9% sodium chloride, 4 mg/mL, IV Bag,  Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6064-1", "product_quantity": "3,980  bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-245576, Exp. 8/2/2023; 36-254436, 36-254442, Exp. 9/5/2023; 36-255131, Exp. 9/6/2023; 36-256045, Exp. 9/11/2023; 36-239523, Exp. 7/12/2023; 36-248987, Exp. 8/16/2023; 36-240797, Exp. 7/17/2023; 36-241979, Exp. 7/24/2023; 36-242705, Exp. 7/26/2023; 36-251733, 36-251738, Exp. 8/29/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1025-2023", "product_description": "CARDIOPLEGIA SOLUTION, LEESBURG CARDIOPLEGIA, IV Bag, Total Volume = 1030.2 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0218-1", "product_quantity": "36 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot:36-255941, Exp. 7/27/2023."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090710"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["57664-228", "57664-229", "57664-230"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091150", "1091392", "1091497"], "spl_id": ["2f1c1df8-491a-08c9-e063-6394a90a1d06"], "spl_set_id": ["1a89b390-0cd5-45cb-9e70-20de44652c56"], "package_ndc": ["57664-228-83", "57664-228-88", "57664-228-08", "57664-228-13", "57664-228-18", "57664-229-83", "57664-229-88", "57664-229-08", "57664-229-13", "57664-229-18", "57664-230-83", "57664-230-88", "57664-230-08", "57664-230-13", "57664-230-18"], "is_original_packager": [true], "upc": ["0357664228883", "0357664229880", "0357664230886"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "92680", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0940-2023", "product_description": "Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.", "product_quantity": "7313 bottles", "reason_for_recall": "Presence of Foreign Substance: Metal embedded in a tablet.", "recall_initiation_date": "20230713", "center_classification_date": "20230724", "termination_date": "20240212", "report_date": "20230802", "code_info": "Lot AC74459, Exp 07/31/2024"}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091246"], "brand_name": ["OXACILLIN"], "generic_name": ["OXACILLIN SODIUM"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-146", "25021-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["OXACILLIN SODIUM"], "rxcui": ["1743547", "1743549"], "spl_id": ["bfe80588-e805-420a-af34-6bd5e8635525"], "spl_set_id": ["f3bee4d7-82d8-4e2d-8fc8-4446e6fbf999"], "package_ndc": ["25021-146-10", "25021-162-24"], "is_original_packager": [true], "unii": ["G0V6C994Q5"]}, "product_type": "Drugs", "event_id": "92678", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0935-2023", "product_description": "Oxacillin for Injection, USP, 1 gram per vial, For IV or IM Use, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  Made in India. NDC 25021-146-10.", "product_quantity": "65,710 vials for 1 g and 2 g strength", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230711", "center_classification_date": "20230721", "report_date": "20230802", "code_info": "Lot: OXG301, Exp 12/31/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1133-2023", "product_description": "oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL, IV Bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6044-1", "product_quantity": "2643 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260031, 36-260027, Exp 10/3/2023; 36-262533,36-262532, 36-262531, 36-262530, 36-262529, 36-262528, 36-262527, Exp 10/9/2023.                 ;"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1066-2023", "product_description": "PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1", "product_quantity": "81,073 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270449, 17-270450, 17-270453, 17-270462, 17-270465, 17-270466, 17-270494, 17-270495, 17-270502, 17-270541, Exp. 7/16/2023; 17-270582, 17-270585, 17-270587, 17-270592, 17-270593, 17-270598, 17-270610, 17-270611, 17-270612, Exp. 7/17/2023; 17-270900, 17-270902, 17-270906, 17-270907, 17-270908, 17-270909, 17-270953, 17-270955, 17-270991, 17-270993, Exp. 7/23/2023; 17-271047, 17-271048, 17-271050, 17-271053, Exp. 7/24/2023; 17-271344, 17-271349, 17-271355, 17-271356, 17-271405, 17-271406, Exp. 7/31/2023; 17-271478, 17-271479, 17-271480, 17-271484, 17-271495, 17-271500, Exp. 7/31/2023; 17-271744, 17-271763, Exp. 8/3/2023; 17-271838, 17-271851, Exp. 8/6/2023; 17-271871, 17-271873, 17-271886, 17-271887, 17-271892, 17-271899, 17-271900, 17-271901, 17-271902, Exp. 8/7/2023; 17-272067, 17-272068, 17-272069, 17-272095, Exp. 8/9/2023; 17-272102, 17-272141, 17-272142, Exp. 8/10/2023; 17-272205, 17-272235, 17-272237, 17-272240, 17-272242, Exp. 8/13/2023; 17-272307, 17-272308, Exp. 8/14/2023; 17-272391, 17-272392, 17-272395, Exp. 8/15/2023; 17-272472, Exp. 8/16/2023; 17-272538, Exp. 8/17/2023; 17-272558, 17-272560, 17-272564, 17-272593, 17-272594, 17-272618, 17-272619, 17-272651, 17-272653, 17-272680, Exp. 8/20/2023; 17-272697, 17-272727, 17-272729, Exp. 8/21/2023; 17-272775, 17-272791, 17-272820, 17-272821, Exp. 8/22/2023; 17-272904, 17-272918, 17-272919, 17-272920, 17-272921, 17-272929, Exp. 8/23/2023; 17-272930, 17-272974, 17-272993, 17-272994, 17-272995, 17-272996, Exp. 8/24/2023; 17-272999, 17-273003, 17-273004, 17-273005, 17-273006, 17-273007, Exp. 8/27/2023; 17-273080, Exp. 8/28/2023; 17-273151, 17-273175, 17-273176, 17-273185, Exp. 8/29/2023; 17-273252, 17-273265, 17-273266, Exp. 8/30/2023; 17-273345, 17-273351, 17-273352, 17-273355, 17-273356, 17-273358, 17-273359, 17-273360, Exp. 8/31/2023; 17-273402, 17-273408, 17-273416, 17-273440, 17-273441, 17-273447, Exp. 9/3/2023; 17-273487, 17-273488, 17-273489, 17-273490, 17-273491, 17-273499, 17-273510, 17-273516, Exp. 9/4/2023; 17-273587, 17-273589, 17-273596, 17-273597, 17-273610, 17-273614, 17-273666, Exp. 9/5/2023; 17-273617, 17-273665, 17-273703, 17-273704, 17-273713, 17-273714, 17-273720, 17-273721, 17-273730, 17-273737, 17-273739, Exp. 9/6/2023; 17-273773, Exp. 9/7/2023; 17-273802, 17-273803, 17-273808, 17-273809, 17-273815, 17-273848, 17-273869, 17-273874, 17-273880, 17-273881, 17-273893, Exp. 9/10/2023; 17-273903, 17-273958, 17-273960, 17-273961, 17-273964, 17-273965, Exp. 9/11/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1126-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 20mg/250ml (80 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7025-1.", "product_quantity": "297 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260037, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1125-2023", "product_description": "PHENYLephrine, added to 0.9% sodium chloride, 10mg/250ml (40mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043,  NDC: 72196-6058-1.", "product_quantity": "586 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260034, 36-260033, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1049-2023", "product_description": "HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2", "product_quantity": "2,228 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270675, 17-270683, Exp. 7/18/2023; 17-271147, 17-271119, Exp. 7/25/2023; 17-271339, Exp. 7/27/2023; 17-271679, Exp. 8/2/2023; 17-272202, Exp. 8/10/2023; 17-272241, Exp. 8/13/2023; 17-272375, Exp. 8/15/2023; 17-272783, Exp. 8/22/2023; 17-273438, 17-273431, Exp. 9/3/2023; 17-273615, Exp. 9/5/2023; 17-273789, 9/7/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1061-2023", "product_description": "fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-5", "product_quantity": "8,146 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270584, 17-270586, 17-270597, 17-270613, Exp. 7/17/2023; 17-270655, 17-270659, 17-270741, Exp. 7/18/2023; 17-270872, 17-270875, Exp. 7/20/2023; 17-271040, 17-271041, 17-271042, 17-271058, 17-271066, 17-271071, 17-271080, Exp. 7/24/2023; 17-271111, 17-271148, 17-271150, 17-271151, 17-271152, 17-271166, Exp. 7/25/2023; 17-271241, 17-271267, Exp. 7/26/2023; 17-271402, 17-271407, 17-271413, 17-271429, Exp. 7/30/2023; 17-271555, 17-271556, 17-271560, 17-271594, Exp. 8/1/2023; 17-271754, Exp. 8/3/2023; 17-271797, 17-271799, 17-271821, 17-271842, Exp. 8/6/2023; 17-271888, 17-271889, Exp. 8/7/2023; 17-271949, 17-271950, Exp. 8/8/2023; 17-272021, 17-272041, Exp. 8/9/2023; 17-272285, 17-272292, 17-272309, 17-272316, Exp. 8/14/2023; 17-272705, 17-272708, 17-272709, 17-272722, 17-272725, Exp. 8/21/2023; 17-272784, 17-272810, Exp. 8/22/2023; 17-272916, Exp. 8/23/2023; 17-272981, 17-272982, 17-272983, 17-272984, Exp. 8/24/2023; 17-273144, 17-273145, 17-273158, 17-273159, 17-273165, Exp. 8/29/2023; 17-273480, 17-273485, 17-273492, 17-273494, 17-273498, Exp. 9/4/2023; 17-273567, 17-273568, 17-273578, 17-273603, Exp. 9/5/2023; 17-273767, 17-273777, 17-273781, Exp. 9/7/2023; 17-273980, Exp. 9/11/2023; 17-274130, 17-274135, Exp. 9/13/2023."}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["SNORESTOP NASOSPRAY 60"], "generic_name": ["STRYCHNOS NUX-VOMICA SEED,ATROPA BELLADONNA,EPHEDRA DISTACHYA FLOWERING TWIG,GOLDENSEAL,POTASSIUM DICHROMATE,TEUCRIUM MARUM,HISTAMINE DIHYDROCHLORIDE LIQUID"], "manufacturer_name": ["Green Pharmaceuticals Inc."], "product_ndc": ["61152-199"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["ATROPA BELLADONNA", "EPHEDRA DISTACHYA FLOWERING TWIG", "GOLDENSEAL", "N.ALPHA.-METHYLHISTAMINE DIHYDROCHLORIDE", "POTASSIUM DICHROMATE", "STRYCHNOS NUX-VOMICA SEED", "TEUCRIUM MARUM"], "spl_id": ["e194696f-0a7f-f303-e053-2a95a90a3c90"], "spl_set_id": ["f4d26053-32aa-4cc9-8460-556acc38fe33"], "package_ndc": ["61152-199-99"], "is_original_packager": [true], "nui": ["N0000185375", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0016962", "M0516536"], "pharm_class_epc": ["Non-Standardized Plant Allergenic Extract [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Plant Proteins [CS]", "Seed Storage Proteins [CS]"], "unii": ["WQZ3G9PF0H", "R55VQ87DP3", "ZW3Z11D0JV", "S6S98U0517", "T4423S18FM", "269XH13919", "10464S0TAA"]}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0885-2023", "product_description": "SnoreStop Naso Spray Bulk, liquid, Distributed by Green Pharma, NDC 61152-199-99", "product_quantity": "200 liters/55 gallon drum", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2436, exp. date: unknown", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1067-2023", "product_description": "fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2", "product_quantity": "1,486 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270811, Exp. 7/19/2023; 17-270954, 17-270983, Exp. 7/23/2023; 17-271231, Exp. 7/26/2023; 17-271690, Exp. 8/2/2023; 17-272204, Exp. 8/13/2023; 17-272684, Exp. 8/20/2023; 17-272992, Exp. 8/24/2023; 17-273053, Exp. 8/28/2023; 17-273436, Exp. 9/3/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1055-2023", "product_description": "HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2", "product_quantity": "2,389 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270530, Exp. 7/16/2023; 17-270871, Exp. 7/20/2023; 17-271153, Exp. 7/25/2023; 17-271275, Exp. 7/26/2023; 17-271417, Exp. 7/30/2023; 17-271671, Exp. 8/2/2023; 17-271883, Exp. 8/7/2023; 17-271992, Exp. 8/8/2023; 17-272050, Exp. 8/9/2023; 17-272103, Exp. 8/10/2023; 17-272368, 17-272369, Exp. 8/15/2023; 17-272451, Exp. 8/16/2023; 17-273172, Exp. 8/29/2023; 17-273782, Exp. 9/7/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1137-2023", "product_description": "dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride,  IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6055-1", "product_quantity": "235 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262537, Exp 9/19/2023.                 ;"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1163-2023", "product_description": "TRP Natural Eyes, Red Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-058-15.", "product_quantity": "8,868 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: FQ001 EXP:07/24", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1005-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with **low calcium** and HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0429-1", "product_quantity": "304 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251203, Exp. 7/10/2023; 36-254924, Exp. 7/22/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0976-2023", "product_description": "oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6043-1", "product_quantity": "6037 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239496, Exp. 7/12/2023; 36-240256, Exp. 7/17/2023; 36-241134, Exp. 7/19/2023; 36-241928, Exp. 7/23/2023; 36-243835, Exp. 7/31/2023; 36-245010, 36-245011, Exp. 8/1/2023; 36-245529, 36-245532, Exp. 8/2/2023; 36-246255, 36-246256, 36-246258, 36-246259, Exp. 8/3/2023; 36-247806, Exp. 8/9/2023; 36-248035, Exp. 8/10/2023; 36-248367, Exp. 8/11/2023; 36-249506, 36-249507, 36-249508, Exp. 8/18/2023; 36-251436, 36-251437, Exp. 8/28/2023; 36-254396, Exp. 9/4/2023"}, {"status": "Terminated", "city": "New Castle", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92950", "recalling_firm": "Marlex Pharmaceuticals, Inc.", "address_1": "65 Lukens Dr", "address_2": "N/A", "postal_code": "19720-2718", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-1169-2023", "product_description": "Digoxin Tablets, USP  0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01", "product_quantity": "94/100 count bottles", "reason_for_recall": "Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.", "recall_initiation_date": "20230825", "center_classification_date": "20230918", "termination_date": "20240417", "report_date": "20230913", "code_info": "Lot # E3810, expiration date 02/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0973-2023", "product_description": "oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6042-1", "product_quantity": "3821 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-241662, Exp. 7/20/2023; 36-242725, Exp. 7/26/2023; 36-243607, Exp. 7/30/2023; 36-243837, 36-243838, Exp. 7/31/2023; 36-245517, 36-245523, 36-245525, 36-245662, Exp. 8/2/2023; 36-247254, 36-247255, Exp. 8/8/2023; 36-247983, Exp. 8/10/2023; 36-254917, Exp. 9/5/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0989-2023", "product_description": "potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL, IV Bag, RX Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6060-1", "product_quantity": "7469 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239332, Exp. 7/11/2023; 36-241113, Exp. 7/18/2023; 36-242467, 7/25/2023; 36-243530, 36-243659, Exp. 7/30/2023; 36-244888, 8/1/2023, 36-245657, 36-245658, Exp. 8/2/2023; 36-246835, Exp. 8/7/2023; 36-247595, Exp. 8/9/2023; 36-248736, Exp. 8/15/2023;  36-248984, 36-248985, Exp. 8/16/2023; 36-250054, 36-250055, 36-250056, 36-250057, 36-250058, Exp. 8/22/2023; 36-251046, 36-251047, 36-251048, 36-251049, Exp. 8/24/2023; 36-251975, Exp. 8/30/2023; 36-255877, 36-255878, 36-255879, Exp. 9/10/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1074-2023", "product_description": "lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1", "product_quantity": "9,517 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-271076, Exp. 7/24/2023; 17-271132, 17-271165, Exp. 7/25/2023; 17-271230, 17-271250, Exp. 7/26/2023; 17-271508, Exp. 7/31/2023; 17-271595, 17-271604, Exp. 8/1/2023;  17-271658, Exp. 8/2/2023; 17-271764, Exp. 8/3/2023; 17-271826, Exp. 8/6/2023; 17-271972, Exp. 8/8/2023; 17-272052, 17-272057, Exp. 8/9/2023; 17-272139, Exp. 8/10/2023; 17-272258, Exp. 8/14/2023; 17-272470, Exp. 8/16/2023; 17-272690, Exp. 8/20/2023; 17-272822, Exp. 8/23/2023; 17-273054, 17-273065, Exp. 8/28/2023; 17-273423, Exp. 9/2/2023; 17-273771, Exp. 9/7/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1070-2023", "product_description": "fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 100 mL, Total FentaNYL 200 mcg/100 mL,  100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-1", "product_quantity": "1,114 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-274485, Exp. 9/19/2023; 17-270783, Exp. 7/19/2023; 17-270882, Exp. 7/20/2023; 17-271430, Exp. 7/30/2023; 17-271509, Exp. 7/31/2023; 17-272224, 17-272238, Exp. 8/13/2023; 17-272704, Exp. 8/21/2023; 17-273147, Exp. 8/29/2023."}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1158-2023", "product_description": "TRP Natural Eyes, Eye Lid Relief, Sterile Eye ointment, Homeopathic 0.14 oz (4 grams), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-165-13.", "product_quantity": "16,500 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: 180001 EXP: 01/25", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1040-2023", "product_description": "CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, IV Bag, total volume = 500 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0105-1", "product_quantity": "72 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251334, Exp. 7/13/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1060-2023", "product_description": "HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2012-1", "product_quantity": "5,259 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270534, Exp. 7/16/2023; 17-270705, Exp. 7/18/2023; 17-270782, 17-270797, 17-270798, Exp. 7/19/2023; 17-270968, Exp. 7/23/2023; 17-271105, 17-271154, Exp. 7/25/2023; 17-271251, Exp. 7/26/2023; 17-271330, Exp. 7/27/2023; 17-271418, Exp. 7/30/2023; 17-271746, 17-271758, Exp. 8/3/2023; 17-272108, Exp. 8/10/2023; 17-272257, Exp. 8/13/2023; 17-272344, 17-272355, Exp. 8/15/2023; 17-272442, Exp. 8/16/2023; 17-272801, Exp. 8/22/2023; 17-273511, Exp. 9/4/2023; 17-273576, 17-273611, Exp. 9/5/2023; 17-274048, 17-274050, Exp. 9/12/2023."}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA209959"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-142"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123111"], "spl_id": ["e0197c3c-55f8-4133-b430-b21c061285bd"], "spl_set_id": ["c4d6d76a-14b8-411a-8019-e2c923c2c532"], "package_ndc": ["69097-142-60"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "92616", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0938-2023", "product_description": "Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60", "product_quantity": "278,538 canisters", "reason_for_recall": "Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).", "recall_initiation_date": "20230627", "center_classification_date": "20230721", "termination_date": "20250306", "report_date": "20230719", "code_info": "Lot # IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0883-2023", "product_description": "Babelyn Diarrhea Drops Homeopathic Remedy, 0.5 fl. oz. (15 mL) bottles, Distributed by Pharmadel LLC, Georgetown, DE NDC 55758-035-01", "product_quantity": "5957 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2413, exp. date Sep-24", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0988-2023", "product_description": "norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg/mL, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC 72196-8095-1", "product_quantity": "80 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-257069, Exp. 9/14/2023."}, {"status": "Ongoing", "city": "Chennai", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91621", "recalling_firm": "Global Pharma Healthcare Private Limited", "address_1": "A - 9 Sidco Pharmaceutical Complex", "address_2": "Thiruporur", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed to two distributors who further distributed Nationwide in the USA.", "recall_number": "D-0920-2023", "product_description": "Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.", "product_quantity": "400,008 bottles total for all products", "reason_for_recall": "CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.", "recall_initiation_date": "20230130", "center_classification_date": "20230714", "report_date": "20230719", "code_info": "Lot #: PCMH009, PCMH010, PCMH011, PCMH012, PCMH013, PCMH014, PCMH015, PCMH016, exp. date Nov-2023; PCMI001, PCMI002, PCMI003, PCMI004, PCMI006, PCMI 07, PCMI 008, Exp. date AUG-2024; PCMJ003, PCMJ007, PCMJ016, Exp. date MAR-2025", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0978-2023", "product_description": "heparin 4000 units/1000mL added to 0.9% sodium chloride, 4 units/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-7022-1", "product_quantity": "11,824 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-243555, 36-243556, Exp. 7/10/2023; 36-245117, 36-245118, 36-245119, 36-245120, Exp. 7/12/2023; 36-246163, 36-246164, Exp. 7/14/2023; 36-247010, Exp. 7/18/2023; 36-248226, 36-248229, 36-248232, 36-248248, Exp. 7/24/2023; 36-249829, 36-249830, 36-249831, 36-249832, Exp. 8/1/2023; 36-250047, 36-250048, 36-250049, 36-250050, Exp. 8/2/2023; 36-250289, 36-250290, 36-250291, 36-250293, Exp. 8/3/2023; 36-251057, 36-251058, 36-251060, Exp. 8/4/2023; 36-251385, 36-251386, 36-251387, 36-251388, Exp. 8/7/2023; 36-251448, 36-251449, 36-251450, Exp. 8/8/2023; 36-252462, Exp. 8/14/2023; 36-254679, 36-254681, Exp. 8/16/2023; 36-255116, 36-255117, 36-255118, Exp. 8/17/2023; 36-255488, Exp. 8/18/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0987-2023", "product_description": "NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043,  NDC: 72196-8097-1", "product_quantity": "I,I87 bags.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-241043, 36-241044, 36-241045, 36-241046, Exp. 7/18/2023."}, {"status": "Completed", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA214554"], "brand_name": ["FOSFOMYCIN TROMETHAMINE"], "generic_name": ["FOSFOMYCIN TROMETHAMINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-749"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOSFOMYCIN TROMETHAMINE"], "rxcui": ["808917"], "spl_id": ["f6a079bc-179c-46e4-9077-96168cdd1cf9"], "spl_set_id": ["48e352bc-52ea-4778-905a-60ef38a5c18a"], "package_ndc": ["67877-749-57"], "is_original_packager": [true], "unii": ["7FXW6U30GY"]}, "product_type": "Drugs", "event_id": "92706", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recall product was distributed nationwide.", "recall_number": "D-1145-2023", "product_description": "Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57", "product_quantity": "99,516 sachets", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.", "recall_initiation_date": "20230718", "center_classification_date": "20230906", "report_date": "20230913", "code_info": "Lot #22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0981-2023", "product_description": "heparin 7500 units added to 0.9% sodium chloride 1000mL, CONCENTRATION = 7.5 units/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-7009-1", "product_quantity": "448 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-256245, 36-256249 Exp. 8/23/2023."}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92690", "recalling_firm": "New England Life Care, Inc. dba Advanced Compounding Solutions", "address_1": "4 Constitution Way Ste L", "address_2": "N/A", "postal_code": "01801-1042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0926-2023", "product_description": "SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10", "product_quantity": "493 syringes", "reason_for_recall": "CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.", "recall_initiation_date": "20230710", "center_classification_date": "20230719", "termination_date": "20231204", "report_date": "20230726", "code_info": "Lot # 20230524-23C29D, Exp 21SEP2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1057-2023", "product_description": "HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2013-1", "product_quantity": "1,389 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270683, Exp 7/18/2023; 17-271119, Exp 7/25/2023; 17-271339, Exp 7/27/2023; 17-272202, Exp 8/10/2023; 17-272241, Exp 8/13/2023; 17-272783, Exp 8/22/2023; 17-273431, Exp 9/3/2023; 17-273615, Exp 9/5/2023"}, {"status": "Ongoing", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050573"], "brand_name": ["SANDIMMUNE"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0109", "0078-0240", "0078-0241", "0078-0110"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["197552", "197553", "205175", "212810", "212844", "212957", "309632", "328160"], "spl_id": ["0b1732c5-125d-4878-867d-b4b9d6d2c50e"], "spl_set_id": ["5e5926a7-1de0-4b54-a5c0-286b6200ff82"], "package_ndc": ["0078-0240-61", "0078-0240-15", "0078-0241-61", "0078-0241-15", "0078-0109-61", "0078-0109-01", "0078-0110-22"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "92975", "recalling_firm": "Novartis Pharmaceuticals Corp.", "address_1": "1 Health Plz", "address_2": "", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1174-2023", "product_description": "SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle,  Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by:  Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, NDC 0078-0110-22.", "product_quantity": "1272 bottles", "reason_for_recall": "Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.", "recall_initiation_date": "20230908", "center_classification_date": "20230921", "report_date": "20230927", "code_info": "FX001691, Exp. 12/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["FEXOFENADINE HYDROCHLORIDE"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["e43b561e-d68a-47af-be93-d710f0f77505"], "spl_set_id": ["e43b561e-d68a-47af-be93-d710f0f77505"], "package_ndc": ["45802-847-78"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0907-2023", "product_description": "Fexofenadine Hydrochloride Tablets, 180 mg, 100-count cartons, Distributed by: Perrigo, Allegan, MI 49010. NDC 45802-847-78", "product_quantity": "15,504 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2DR0351, Exp. date 12/23", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1122-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10% with CALCIUM and HEPARIN, IV Bags, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0422-1", "product_quantity": "108 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260017, Exp 8/19/2023      ;"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0951-2023", "product_description": "dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%,  IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6054-1", "product_quantity": "2,260 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-243946, 36-243947, 36-243948, 36-243949, Exp. 7/11/2023; 36-255120, Exp. 8/17/2023; 36-246829, 36-246831, 36-246832, Exp. 7/18/2023; 36-255961, Exp. 8/21/2023; 36-256896, Exp. 8/25/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1046-2023", "product_description": "fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2", "product_quantity": "100 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-273267, Exp. 8/31/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1123-2023", "product_description": "CARDIOPLEGIA SOLUTION, 25 mEq K, SUTTER CARDIOPLEGIA, Total Volume = 572.64 mL, IV Bag,  Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0217-1", "product_quantity": "16 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262542, Exp 8/25/2023      ;"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1028-2023", "product_description": "CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, High Potassium, IV Bag, total volume = 830 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0100-1", "product_quantity": "196 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251685, Exp. 7/15/2023; 36-252364, 7/17/2023"}, {"status": "Terminated", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92786", "recalling_firm": "Parker Laboratories, Inc.", "address_1": "286 Eldridge Rd", "address_2": "N/A", "postal_code": "07004-2509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States, Singapore, Korea and Hong Kong", "recall_number": "D-1091-2023", "product_description": "Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004", "product_quantity": "8", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230802", "center_classification_date": "20230818", "termination_date": "20240603", "report_date": "20230830", "code_info": "Lot #: a) A1221010, Exp. Date 12/9/2023, b) A1221011, Exp date 12/9/2023"}, {"status": "Completed", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92979", "recalling_firm": "Hua Da Trading, Inc. dba Wefun Inc.", "address_1": "6306 20th Ave", "address_2": "", "postal_code": "11204-3049", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1180-2023", "product_description": "WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5", "product_quantity": "300 cartons", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20230825", "center_classification_date": "20230929", "report_date": "20230920", "code_info": "Lot # #18520168, Exp. date 09/30/2026  .", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0977-2023", "product_description": "heparin 2500 units/500mL added to 0.9% sodium chloride 5 units/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-8100-1", "product_quantity": "7,509 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-243815, 36-243816, Exp. 7/11/2023; 36-247675, 36-247676, Exp. 7/20/2023; 36-247837, Exp. 7/21/2023; 36-248988, 36-248989, Exp. 7/27/2023; 36-249594, 36-249595, Exp. 7/29/2023; 36-249833, Exp. 8/1/2023; 36-251054, 36-251055, 36-251056, Exp. 8/4/2023; 36-251943, 36-251951, 36-251961, Exp. 8/10/2023; 36-254376, 36-254377, 36-254378, Exp. 8/15/2023; 36-254689, 36-254691, 36-254692, Exp. 8/16/2023; 36-255493, Exp. 8/18/2023; 36-255945, 36-255946, 36-255957, Exp. 8/21/2023."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA212450"], "brand_name": ["LOTEPREDNOL ETABONATE"], "generic_name": ["LOTEPREDNOL ETABONATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-232"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["LOTEPREDNOL ETABONATE"], "rxcui": ["311382"], "spl_id": ["19d17bf3-2231-4af9-b1da-ca74f015b72d"], "spl_set_id": ["36cfd5b8-c892-44e1-aaed-fb32d7aeca7c"], "package_ndc": ["62756-232-90", "62756-232-55", "62756-232-56"], "is_original_packager": [true], "unii": ["YEH1EZ96K6"]}, "product_type": "Drugs", "event_id": "92637", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0924-2023", "product_description": "Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.", "product_quantity": "20,884 cartons", "reason_for_recall": "Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.", "recall_initiation_date": "20230705", "center_classification_date": "20230717", "termination_date": "20240226", "report_date": "20230726", "code_info": "Lot#: a) BAC0334A, Exp 06/2023; BAC0532A, Exp 11/2023 BAD0407A, Exp 08/2024 BAD0425A, Exp 08/2024; b) BAC0335A, Exp 06/2023, BAC0533A, Exp 10/2023, BAD0148A, Exp 03/2024, BAD0320A, Exp 07/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Campbell", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA022523"], "brand_name": ["PANCREAZE"], "generic_name": ["PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE"], "manufacturer_name": ["VIVUS LLC"], "product_ndc": ["62541-401", "62541-402", "62541-403", "62541-404", "62541-405", "62541-406"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANCRELIPASE AMYLASE", "PANCRELIPASE LIPASE", "PANCRELIPASE PROTEASE"], "rxcui": ["1806919", "1806921", "1806924", "1806926", "1806929", "1806931", "1806964", "1806966", "2478453", "2478455", "2564410", "2564412"], "spl_id": ["36e934b1-3fbb-8f0c-e063-6294a90a968c"], "spl_set_id": ["e8f5d2fe-728d-42af-99a6-83dddc6539c5"], "package_ndc": ["62541-402-10", "62541-403-10", "62541-404-10", "62541-405-10", "62541-401-10", "62541-406-50", "62541-406-10"], "is_original_packager": [true], "upc": ["0362541402102", "0362541403109", "0362541405103", "0362541401105", "0362541406100", "0362541404106", "362541401105"], "unii": ["3560D81V50", "YOJ58O116E", "8MYC33932O"]}, "product_type": "Drugs", "event_id": "92582", "recalling_firm": "Vivus, Inc.", "address_1": "900 E Hamilton Ave Ste 550", "address_2": "N/A", "postal_code": "95008-0643", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0896-2023", "product_description": "PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,", "product_quantity": "4240 bottles", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20230623", "center_classification_date": "20230707", "report_date": "20230719", "code_info": "Lot #: 102101, Exp: 31 July 2024", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0999-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCIUM, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0405-1", "product_quantity": "84 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251696, Exp. 7/15/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0952-2023", "product_description": "glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1", "product_quantity": "770 Syringes", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-247022, Exp 08/07/2023; 36-239877, Exp 07/13/2023; 36-241448, Exp 07/20/2023; 36-251782, Exp 08/29/2023"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92425", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "USA nationwide", "recall_number": "D-0891-2023", "product_description": "Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01", "product_quantity": "12960 vials", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20230530", "center_classification_date": "20230629", "termination_date": "20231218", "report_date": "20230705", "code_info": "Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["CAREONE ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Retail Business Services, LLC"], "product_ndc": ["72476-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["4679cef1-6a61-4814-9013-b631d7ced002"], "spl_set_id": ["ce398856-e9a6-401d-8636-bc5771a7e28b"], "package_ndc": ["72476-847-22", "72476-847-39", "72476-847-95"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0902-2023", "product_description": "Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons, Distributed By: Adusa Distribution, LLC, Salisbury, NC 28147.  NDC 72476-847-22", "product_quantity": "3,240 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2JE2185, Exp. date 01/24", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0953-2023", "product_description": "dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride,  IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6055-1", "product_quantity": "3,699 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-244893, 36-244894, 36-244895, Exp. 7/12/2023; 36-246428, 36-246429, 36-246647, 36-246648, Exp. 7/14/2023; 36-254364, 36-254365, 36-254366, 36-254367, 36-254368, Exp. 8/15/2023; 36-246824, 36-246825, 36-246828, Exp. 7/18/2023; 36-256157, Exp. 8/21/2023; 36-256890, Exp. 8/25/2023."}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["STELLALIFE VEGA ORAL CARE"], "generic_name": ["SPRAY"], "manufacturer_name": ["StellaLife, Inc."], "product_ndc": ["69685-111", "69685-112", "69685-115"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL", "SUBLINGUAL"], "substance_name": ["ARNICA MONTANA", "CALCIUM SULFIDE", "CALENDULA OFFICINALIS FLOWERING TOP", "DELPHINIUM STAPHISAGRIA SEED", "ECHINACEA ANGUSTIFOLIA", "ECHINACEA PURPUREA", "HYPERICUM PERFORATUM", "LEDUM PALUSTRE TWIG", "MATRICARIA RECUTITA", "RUTA GRAVEOLENS FLOWERING TOP", "SILICON DIOXIDE", "STRYCHNOS IGNATII SEED"], "spl_id": ["0ec6364c-264e-609d-e063-6394a90ae0eb"], "spl_set_id": ["b8ba495e-2cfe-092c-e053-2995a90a3fd3"], "package_ndc": ["69685-112-01", "69685-115-01", "69685-111-01"], "is_original_packager": [true], "unii": ["00543AP1JV", "18E7415PXQ", "QI7G114Y98", "1MBW07J51Q", "O80TY208ZW", "XK4IUX8MNB", "VB06AV5US8", "877L01IZ0P", "G0R4UBI2ZZ", "N94C2U587S", "1NM3M2487K", "ETJ7Z6XBU4"]}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0890-2023", "product_description": "StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Peppermint, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-112-01", "product_quantity": "33,109/1 fl. oz. tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot #2407, exp. date Feb-24; 2409A, exp. date Apr-24; 2409B, exp. date May-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["MAJOR LUBRIFRESH PM"], "generic_name": ["MINERAL OIL AND WHITE PETROLATUM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6488"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["MINERAL OIL", "PETROLATUM"], "rxcui": ["746083", "1086613"], "spl_id": ["52923204-c19e-4f8c-8322-12b29bcdb4a3"], "spl_set_id": ["bd85d4b6-7093-4e89-ae7b-2a293a0775f2"], "package_ndc": ["0904-6488-38"], "is_original_packager": [true], "upc": ["0309046488385"], "unii": ["T5L8T28FGP", "4T6H12BN9U"]}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1160-2023", "product_description": "MAJOR LubriFresh P.M. Nighttime Ointment, Lubricant Eye Ointment, Sterile, 0.125 OZ (3.5g), Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, Made in Jordan, NDC: 0904-6488-38.", "product_quantity": "282,564 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: 184001 EXP: 11/24; 184002 EXP: 11/24; 184003 EXP: 11/24; Lot: 184004 EXP: 12/24; Lot: 184005 EXP: 12/24; Lot:184006 EXP:12/24;", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0966-2023", "product_description": "vancomycin 1.5 g/250 mL added to 0.9% sodium chloride, 6 mg/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6076-1", "product_quantity": "3,648 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239524, Exp. 7/12/2023; 36-240843, Exp. 7/18/2023; 36-241437, Exp. 7/20/2023; 36-242698, Exp. 7/26/2023; 36-243152, Exp. 7/27/2023; 36-245567, Exp. 8/2/2023; 36-251063, Exp. 8/24/2023; 36-252193, Exp. 8/31/2023; 36-255122, 36-255123, 36-255124, Exp. 9/6/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1027-2023", "product_description": "CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1, Plasmalyte/Tromethamine, High Potassium, IV Bags, total volume = 500 mL, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043,  NDC: 72196-0111-1", "product_quantity": "132 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254403, Exp. 7/21/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1013-2023", "product_description": "oxyTOCIN, 40 units added to 0.9% sodium chloride 1000 mL, IV Bag, Rx Only, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-8069-1", "product_quantity": "2692 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-241803, 36-241804, Exp. 7/21/2023; 36-243836, Exp. 7/31/2023; 36-246645, Exp. 8/3/2023; 36-246729, Exp. 8/6/2023; 36-248976, Exp. 8/16/2023; 36-249502, Exp. 8/17/2023; 36-252215, 8/31/2023; 36-255872, 36-255875, Exp. 9/10/2023"}, {"status": "Completed", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92857", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "N/A", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1096-2023", "product_description": "Blis-To-Sol Liquid (Tolnaftate), 1%, packaged in a) 1 FLUID OZ. (29.5 mL) bottles, UPC 0 11169 20011 8 and b) 1.85 FLUID OZ. (54.5 mL) bottles, UPC 0 11169 20012 5, Distributed by Oakhurst Company, Levittown, NY 11756.", "product_quantity": "a) 9816 bottles; b) 10,776 bottles", "reason_for_recall": "CGMP Deviations: Products not manufactured under current good manufacturing practices.", "recall_initiation_date": "20230809", "center_classification_date": "20230824", "report_date": "20230830", "code_info": "Lot: 9E098A"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090382"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-933", "64380-934", "64380-935"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["ff308b3c-902c-4149-addb-ec8d5dfbf00c"], "spl_set_id": ["a8817f22-8478-49b9-8354-ab27ca222c6b"], "package_ndc": ["64380-933-04", "64380-933-05", "64380-933-08", "64380-934-04", "64380-934-05", "64380-934-08", "64380-935-04", "64380-935-05", "64380-935-08"], "is_original_packager": [true], "upc": ["0364380933083", "0364380935049", "0364380933045", "0364380934042", "0364380934059", "0364380934080", "0364380933052", "0364380935087", "0364380935056"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "92584", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0895-2023", "product_description": "Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08", "product_quantity": "2,700 HDPE Bottles", "reason_for_recall": "Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.", "recall_initiation_date": "20230626", "center_classification_date": "20230706", "termination_date": "20240515", "report_date": "20230712", "code_info": "Lot#: 7901903A, exp. date 04/2024"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0985-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10%, Total Volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0400-1", "product_quantity": "128 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251458, Exp. 7/14/2023; 36-251695, Exp. 7/15/2023; 36-256027, Exp. 7/28/2023."}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0882-2023", "product_description": "Bebelyn Colic Drops Homeopathic Remedy, 0.5 FL Oz (15 mL) bottles, distributed by Pharmadel LLC Georgetown, DE NDC 55758-036-01", "product_quantity": "5,956 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2414, exp. date Sep-24", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1136-2023", "product_description": "vancomycin added to 0.9% Sodium Chloride, 1.25 g/250 mL (5 mg/mL), 250mL Excel Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6074-1", "product_quantity": "477 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262215, 36-262216, Exp 10/5/2023.                 ;"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1108-2023", "product_description": "CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, HIGH POTASSIUM, Total Volume = 830 mL, EVA Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0100-1", "product_quantity": "184", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262513, Exp 8/25/2023; 36-262880, Exp 8/27/2023"}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091246"], "brand_name": ["OXACILLIN"], "generic_name": ["OXACILLIN SODIUM"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-146", "25021-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["OXACILLIN SODIUM"], "rxcui": ["1743547", "1743549"], "spl_id": ["bfe80588-e805-420a-af34-6bd5e8635525"], "spl_set_id": ["f3bee4d7-82d8-4e2d-8fc8-4446e6fbf999"], "package_ndc": ["25021-146-10", "25021-162-24", "25021-162-68"], "is_original_packager": [true], "unii": ["G0V6C994Q5"]}, "product_type": "Drugs", "event_id": "92678", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0936-2023", "product_description": "Oxacillin for Injection, USP, 2 grams per vial, For IV or IM Use, Rx only, labeled as a) NDC 25021-162-24 and b) novaplus NDC 25021-162-68, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  Made in India.", "product_quantity": "65,710 vials for 1 g and 2 g strength", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230711", "center_classification_date": "20230721", "report_date": "20230802", "code_info": "Lot #: a) OXL202, exp 6/30/2025; OXL204, exp 6/30/2025; OXL301, exp 12/31/2025; OXL205, exp 11/30/2025; b) OXL201, exp 5/31/2025; OXL203, exp 6/30/2025"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217230"], "brand_name": ["RUFINAMIDE"], "generic_name": ["RUFINAMIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-616", "59651-617"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RUFINAMIDE"], "rxcui": ["824295", "824301"], "spl_id": ["96d61d77-4de0-4c57-997d-014010177a86"], "spl_set_id": ["d9ffc833-d902-41cb-8e8e-6bbba8e65b9e"], "package_ndc": ["59651-616-08", "59651-617-08"], "is_original_packager": [true], "upc": ["0359651616086"], "unii": ["WFW942PR79"]}, "product_type": "Drugs", "event_id": "92756", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-1087-2023", "product_description": "Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by:  Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-616-08", "product_quantity": "48 bottles", "reason_for_recall": "cGMP deviations: Batch was released prior to approval.", "recall_initiation_date": "20230721", "center_classification_date": "20230818", "termination_date": "20240226", "report_date": "20230830", "code_info": "Lot #: RB2023001A, Exp 02/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1132-2023", "product_description": "oxyTOCIN 30 units added to Lactated Ringer's 500 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6039-1", "product_quantity": "1,996 bags.", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260043, 36-260039, Exp 9/8/2023; 36-262220, Exp 9/10/2023; 36-262526, 36-262525, 36-262524, Exp 9/14/2023.                 ;"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1134-2023", "product_description": "oxyTOCIN, 40 units added to 0.9% sodium chloride 1000 mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-8069-1", "product_quantity": "298 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260050, Exp 10/3/2023.                 ;"}, {"status": "Terminated", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92786", "recalling_firm": "Parker Laboratories, Inc.", "address_1": "286 Eldridge Rd", "address_2": "N/A", "postal_code": "07004-2509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States, Singapore, Korea and Hong Kong", "recall_number": "D-1092-2023", "product_description": "Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004", "product_quantity": "40", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230802", "center_classification_date": "20230818", "termination_date": "20240603", "report_date": "20230830", "code_info": "Lot #: a) J1121010, Exp. Date 12/16/2023, b) A0921006, Exp. Date 8/16/2023, c) A0921007, Exp. Date 8/16/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1004-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM and HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043. NDC: 72196-0419-1", "product_quantity": "224 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251207, Exp. 7/10/2023; 36-256337, Exp. 7/29/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0961-2023", "product_description": "PHENYLephrine 20mg/250ml added to 0.9% sodium chloride, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7025-1.", "product_quantity": "8,363 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot:36-239194, 36-239195, Exp.7/10/2023; 36-240009, Exp. 7/13/2023; 36-240799, Exp.7/17/2023; 36-241147, 36-241148, Exp.  7/19/2023; 36-241740, 36-241741, Exp. 7/21/2023; 36-242562, Exp. 7/25/2023; 36-243531, Exp. 7/30/2023; 36-244886, 36-244961, Exp. 8/1/2023; 36-246713, 36-246714, 36-24671, 536-246716, Exp. 8/6/2023; 36-247344, 36-247345, 36-247347, 36-247348, 36-247349, 36-247350, Exp. 8/8/2023; 36-247823, 36-247824,  36-247825, 36-247826, Exp. 8/10/2023; 36-248356, 36-248358, Exp. 8/11/2023; 36-249226, Exp. 8/17/2023; 36-251966, Exp. 8/30/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0949-2023", "product_description": "succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue Pheonix, AZ, NDC 72196-6011-2.", "product_quantity": "26,208 Syringes", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-238812, 36-238813, 36-238814, 36-238815, 36-238816, 36-238819, Exp. 7/10/2023; 36-239281, 36-239282, 36-239284, Exp. 7/11/2023; 36-239459, 36-239460, 36-239628, 36-239629, Exp. 7/12/2023; 36-239879, 36-239880, 36-239881, Exp. 7/13/2023; 36-240272, Exp. 7/16/2023; 36-240512, 36-240513, 36-240514, 36-240515, 36-240724, Exp. 7/17/2023; 36-240991, 36-240992, 36-240993, Exp. 7/18/2023; 36-241267, 36-241269, Exp. 7/19/2023; 36-241364, 36-241366, 36-241367, 36-241368, Exp. 7/20/2023; 36-241669, 36-241670, 36-241735, Exp. 7/21/2023; 36-242079, 36-242080, 36-242081, 36-242082, 36-242083, 36-242084, 36-242085, Exp. 7/24/2023; 36-242624, 36-242627, 36-242628, 36-242629, Exp. 7/26/2023; 36-243046, 36-243047, 36-243048, 36-243049, 36-243050, 36-243051, 36-243052, Exp. 7/27/2023; 36-243824, 36-243825, 36-243826, 36-243827, 36-243828, Exp. 7/31/2023; 36-244791, Exp. 8/01/2023; 36-245798, 36-245799, 36-245800, 36-245801, 36-245802, Exp. 8/02/2023; 36-246701, Exp. 8/06/2023; 36-249000, 36-249002, Exp. 8/16/2023; 36-249509, 36-249515, Exp. 8/18/2023; 36-251029, 36-251030, 36-251031, Exp. 8/24/2023; 36-251327, 36-251328, 36-251331, Exp. 8/27/2023; 36-251825, 36-251826, 36-251827, Exp. 8/30/2023"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1156-2023", "product_description": "TRP Natural Eyes, Dryness Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-096-19.", "product_quantity": "83,898 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: FR001 EXP: 07/24; Lot: FR004 EXP: 04/25; Lot:FR005 EXP: 04/25; Lot:FR006 EXP: 04/25; Lot: FR007 Exp: 04/25", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["GOOD SENSE ALLER EASE"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["L. Perrigo Company"], "product_ndc": ["0113-0847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["5cd21fe5-5a25-4beb-a480-924996e65ee1"], "spl_set_id": ["e533a008-b437-401e-ab50-bda31e6662d3"], "package_ndc": ["0113-0847-39", "0113-0847-95", "0113-0847-22", "0113-0847-00", "0113-0847-47"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0908-2023", "product_description": "Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 0113-0847-39), and b) 45-count cartons (NDC 0113-0847-95), Distributed by: Perrigo, Allegan, MI 49010.", "product_quantity": "32,376 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: a) 2DV1869, 2EV1613, 2EV1614, Exp. date 12/23; 2EV1820, 2FV1943, Exp. date 01/24; 2GV1893, Exp. date 04/24. Lot #: b) 2CR0653, 2DR0466, Exp. date 12/23, 2ER2087, Exp. date 01/24", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0967-2023", "product_description": "vancomycin 1.5 g/500 mL added to 0.9% sodium chloride, 3 mg/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6176-1", "product_quantity": "6,772 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-238968, 36-238985, 36-238992, 36-238998, Exp. 7/10/2023; 36-240784, 36-240785, 36-240786, 36-240787, Exp. 7/17/2023; 36-240840, 36-240842, Exp. 7/18/2023; 36-243157, Exp. 7/27/2023; 36-243953, Exp. 7/31/2023; 36-251050, 36-251051, 36-251059, Exp. 8/24/2023; 36-252196, 36-252197, 36-252200, Exp. 8/31/2023; 36-254418, Exp. 9/5/2023; 36-256916, Exp. 9/13/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1072-2023", "product_description": "fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2", "product_quantity": "896 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270540, Exp. 7/16/2023; 17-270663, Exp. 7/18/2023; 17-271059, Exp. 7/24/2023; 17-271249, Exp. 7/26/2023; 17-271593, Exp. 8/1/2023; 17-271742, Exp. 8/3/2023; 17-272064, Exp. 8/9/2023; 17-272106, Exp. 8/10/2023; 17-272279, Exp. 8/14/2023; 17-272530, Exp. 8/17/2023; 17-272603, Exp. 8/20/2023; 17-272776, Exp. 8/22/2023; 17-273075, Exp. 8/28/2023; 17-273344, Exp. 8/31/2023; 17-273409, Exp. 9/3/2023; 17-274221, 17-274222, Exp. 9/14/2023; 17-274414, Exp. 9/18/2023."}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1166-2023", "product_description": "TRP Natural Eyes, Twitching Relief, Sterile Eye Ointment, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-099-15.", "product_quantity": "8,819", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot:DD001 EXP: 07/24;", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0984-2023", "product_description": "oxyTOCIN 20 units added to Lactated Ringer's 1000 mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6038-1", "product_quantity": "9504 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-247256, 36-247525, 36-247259, Exp. 7/14/2023; 36-247782, 36-247784, Exp. 7/15/2023; 36-247980, Exp. 7/16/2023; 36-248274, 36-248275, Exp. 7/19/2023; 36-248732, 36-248733, 36-248734, 36-248735, Exp. 7/21/2023; 36-248971, 36-248990, Exp. 7/22/2023; 36-249510, 36-249511, 36-249512, Exp. 7/24/2023; 36-249722, 36-249723, Exp. 7/26/2023; 36-251196, 36-251198, Exp. 7/30/2023; 36-251431, 36-251432, 36-251433, Exp. 8/3/2023; 36-251985, 36-251986, 36-251987, 36-251989, Exp. 8/5/2023; 36-256901, 36-256902, 36-256903, 36-256904, 36-256906, Exp. 8/20/2023"}, {"status": "Ongoing", "city": "Arlington", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92884", "recalling_firm": "Inmar Supply Chain Solutions, LLC", "address_1": "1131 W Bardin Rd Ste 131", "address_2": "N/A", "postal_code": "76017-6082", "voluntary_mandated": "N/A", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.", "recall_number": "D-1104-2023", "product_description": "All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.", "recall_initiation_date": "20230814", "center_classification_date": "20230824", "report_date": "20230830", "code_info": "Miscellaneous"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1044-2023", "product_description": "HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2010-1", "product_quantity": "2,717 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270603, Exp. 7/17/2023; 17-270802, Exp. 7/19/2023; 17-271073, Exp. 7/24/2023; 17-271129, Exp. 7/25/2023; 17-271254, Exp. 7/26/2023; 17-271953, Exp. 8/8/2023; 17-272022, Exp. 8/9/2023; 17-272295, Exp. 8/14/2023; 17-272616, Exp. 8/20/2023; 17-273357, Exp. 8/31/2023; 17-273501, Exp. 9/4/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1078-2023", "product_description": "PHENYLephrine in 0.9 sodium chloride, 400 mcg /10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6007-1", "product_quantity": "16,971 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270510, 17-270512, Exp. 7/16/2023;  17-270665, 17-270699, Exp. 7/18/2023; 17-270812, Exp. 7/19/2023; 17-271062, 17-271063, 17-271064, 17-271065, Exp. 7/24/2023; 17-271350, 17-271357, 17-271421, 17-271422, Exp. 7/30/2023; 17-271836, 17-271848, Exp. 8/6/2023; 17-271890, Exp. 8/7/2023; 17-271943, 17-271954, 17-271958, 17-271962, Exp. 8/8/2023; 17-272162, 17-272174, 17-272175, 17-272176, 17-272177, Exp. 8/13/2023; 17-272444, 17-272456, 17-272473, Exp. 8/16/2023; 17-272717, 17-272721, 17-272732, Exp. 8/21/2023; 17-273550, 17-273565, 17-273579, 17-273580, Exp. 9/5/2023."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213424"], "brand_name": ["ATROPINE SULFATE"], "generic_name": ["ATROPINE SULFATE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-512"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ENDOTRACHEAL", "INTRAMEDULLARY", "INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["ATROPINE SULFATE"], "rxcui": ["1190776"], "spl_id": ["275def6c-5b2d-918b-e063-6294a90aa71f"], "spl_set_id": ["f3cb74e9-b4ac-4efe-bd8e-8a71970ee7c7"], "package_ndc": ["16729-512-05", "16729-512-43"], "is_original_packager": [true], "upc": ["0316729512053"], "unii": ["03J5ZE7KA5"]}, "product_type": "Drugs", "event_id": "92639", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0917-2023", "product_description": "Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials,  Rx only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-512-43.", "product_quantity": "2348 vials", "reason_for_recall": "Presence of Particulate Matter: Particulate matter identified as fiber.", "recall_initiation_date": "20230703", "center_classification_date": "20230713", "termination_date": "20241017", "report_date": "20230719", "code_info": "Lot #: M2210154 Exp. date 06/2025; M2212575 Exp. date 08/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0888-2023", "product_description": "StellaLife VEGA Oral Care Spray, 1 fl oz (30 ml) bottles, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-101-02", "product_quantity": "40,034/1 fl. oz tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2335, exp. date Sep-23; 2364, exp. date Nov-23; 2408, exp. date Feb-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1155-2023", "product_description": "TRP Natural Eyes, Dryness Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC:17312-178-15.", "product_quantity": "196,111 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: IX001 EXP: 07/24; Lot: IX002 EXP: 12/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Chennai", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91621", "recalling_firm": "Global Pharma Healthcare Private Limited", "address_1": "A - 9 Sidco Pharmaceutical Complex", "address_2": "Thiruporur", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed to two distributors who further distributed Nationwide in the USA.", "recall_number": "D-0922-2023", "product_description": "Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.", "product_quantity": "400,008 bottles total for all products", "reason_for_recall": "CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.", "recall_initiation_date": "20230130", "center_classification_date": "20230714", "report_date": "20230719", "code_info": "Lot #: PCMH003, PCMH004, PCMH006, PCMH008, Exp. date NOV-2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1071-2023", "product_description": "ketamine  in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1", "product_quantity": "2,994 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-274122, 17-274147, 17-274155, 17-274158, 17-274162, Exp. 9/13/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1009-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0431-1", "product_quantity": "244 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251452, Exp. 7/14/2023; 36-254918, Exp. 7/22/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1008-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIUM and HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043,  NDC: 72196-0421-1", "product_quantity": "124 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254913, Exp. 7/22/2023; 36-256706, 7/30/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0990-2023", "product_description": "potassium phosphate, 30 mmole added to 0.9% sodium Chloride 500mL, IV Bag, RX Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-7016-1", "product_quantity": "234 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-256240, Exp.9/12/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1035-2023", "product_description": "CARDIOPLEGIA SOLUTION, 12 mEq K, Maintenance 4:1 in Ringer's Low Potassium, IV Bag, total volume = 504.8 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0205-1", "product_quantity": "172 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-253948, Exp. 7/20/2023; 36-255217, Exp. 7/23/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1124-2023", "product_description": "PHENYLephrine 1,000 mcg/10mL, (100mcg/mL) in 0.9% sodium chloride, 10 mL Syringe, Rx Only, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6009-1", "product_quantity": "4100 syringes", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262312, 36-262314, 36-262311, 36-262313, Exp 10/5/2023; 36-262739, 36-262742, 36-262741, 36-262740, 36-262738, 36-262737, Exp 10/11/2023.              ;"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1029-2023", "product_description": "CARDIOPLEGIA SOLUTION,  106 mEq K, Modified St. Thomas Solution High Potassium High Sodium Bicarbonate, IV Bag, Total Volume = 1000 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0204-1", "product_quantity": "144 bags.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot:36-253949, Exp. 7/20/2023; 36-255411, Exp. 7/23/2023."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0974-2023", "product_description": "heparin 2500 units added to 0.9% sodium chloride 250mL, CONCENTRATION = 10 units/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-8000-1", "product_quantity": "358 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-249694, 36-249695, Exp. 7/31/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1065-2023", "product_description": "morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2040-3", "product_quantity": "720 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270814, Exp. 7/19/2023; 17-271253, Exp. 7/26/2023; 17-271336, Exp. 7/27/2023; 17-271689, Exp. 8/2/2023."}, {"status": "Completed", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA216078"], "brand_name": ["BENDAMUSTINE HYDROCHLORIDE"], "generic_name": ["BENDAMUSTINE HYDROCHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["10019-079"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["BENDAMUSTINE HYDROCHLORIDE"], "rxcui": ["1726097"], "spl_id": ["373fbca7-1ae3-4f1d-bba0-bcc312532de2"], "spl_set_id": ["766b73e2-49bb-47f9-bbb1-44cfa1a3197e"], "package_ndc": ["10019-079-01"], "is_original_packager": [true], "unii": ["981Y8SX18M"]}, "product_type": "Drugs", "event_id": "92887", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-1103-2023", "product_description": "Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.", "product_quantity": "13,502 vials", "reason_for_recall": "Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.", "recall_initiation_date": "20230814", "center_classification_date": "20230824", "report_date": "20230830", "code_info": "Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0954-2023", "product_description": "EPINEPHrine 4mg/250mL added to 0.9% sodium chloride, IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-8093-1.", "product_quantity": "9,121 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239250, Exp. 7/10/2023; 36-240225, Exp.7/16/2023; 36-241268, 36-241270, Exp. 7/19/2023; 36-241443, Exp. 7/20/2023; 36-242436, 36-242439, Exp. 7/25/2023; 36-241443, Exp. 7/20/2023; 36-242436, 36-242439, Exp. 7/25/2023; 36-243517, 36-243738, Exp. 7/30/2023; 36-245656, Exp. 8/2/2023; 36-246154, 36-246169, 36-246672, 36-246673, 36-246674, Exp. 8/3/2023; 36-247015, 36-247016, 36-247017, Exp. 8/7/2023; 36-247339, 36-247341, 36-247342, 36-247343, Exp. 8/8/2023; 36-249466, 36-249467, Exp. 8/17/2023; 36-249591, 36-249592, Exp. 8/18/2023; 36-251338, Exp. 8/27/2023; 36-251940, Exp. 8/30/2023; 36-254371, 36-254372, 36-254373, 36-254375, Exp. 9/4/2023."}]